|
His Highness Sheikh
Hasher bin Maktoum bin Juma
Al Maktoum inaugurates 2023
edition of the PrecisionMed
Exhibition & Summit
(Dubai, UAE) -
His Highness Sheikh
Hasher bin Maktoum bin Juma
Al Maktoum, Chairman of
Dubai Media Incorporated,
inaugurated the 2023 edition
of the PrecisionMed
Exhibition & Summit (PMES)
2023 being held today and
tomorrow at the Dubai World
Trade Centre. HH Sheikh
Hasher bin Maktoum toured
the exhibition and summit
accompanied by dignitaries.
The Middle East’s
leading event dedicated to
the advancement of precision
medicine offers an important
opportunity for key
stakeholders, such as
regulators, providers, and
researchers, to draw work
together to drive further
progress in healthcare in
the region.
In a
special recorded message at
today’s opening of PMES 23,
Her Excellency Sarah
Al Amiri – Minister of State
for Public Education and
Advanced Technology at the
Ministry of Industry and
Advanced Technology (MoIAT)
in the United Arab Emirates,
and Secretary-general of the
Emirates Genome Council –
explained that it was
fitting for these
stakeholders to gather in
the Emirates given its role
as a hub for healthcare
transformation and
advancement.
H.E. Al
Amiri stated: “This
gathering of scientists,
physicians, policymakers,
entrepreneurs, and investors
is an important part of the
evolution of healthcare and
medical technology, and it
is fitting that the industry
is meeting here in the UAE,
where technology, innovation
and entrepreneurism
converge. The last few years
have shown just how rapidly
medical advances can be made
when governments,
regulators, businesses, and
researchers all move in the
same direction. The world
demonstrated when we are
laser-focused on overcoming
a common challenge, we can
mobilize resources and
capabilities to accelerate
innovation and supercharge
scientific development. Now
– more than ever, we must
draw on our combined
strength to drive further
progress in healthcare.”
Highlighting that the
world’s population is set to
hit 8.5 billion by 2030,
placing even greater strain
on public health, H.E. Al
Amiri continued: “By
investing in transformative
healthcare solutions today,
we can help create
healthier, happier
societies, even as
populations expand.
Precision medicine is one of
the critical areas that will
change how healthcare
systems operate, enhance
quality of life, and help
achieve the UN’s Sustainable
Development Goals.” H.E. Al
Amiri also highlighted the
UAE’s National Genome
Strategy, launched in March
of this year, which aims to
develop capabilities and
implement genome-based
programs over the next
decade.
“The strategy
will lead to pioneering
precision medicine
applications that could
transform public health, not
only helping to provide the
best healthcare and quality
of life for people, but also
providing significant
opportunities for businesses
and investors,” H.E. Al
Amiri added.
Taking
place 23-24 May 2023 at the
Dubai World Trade Centre,
PMES 23 brings together key
figures in healthcare, with
talks focusing on the
clinical applications of
precision medicine in
cancer, rare diseases,
pharmacogenomics, and stem
cell and gene therapies.
The program also
features talks and exhibits
on the latest in advanced AI
applications in personalized
medicine, and how AI and
other technological advances
in precision medicine are
directly helping patients’
journeys.
In his
opening remarks, His
Excellency Dr. Amin Hussein
Al Amiri, Assistant
Undersecretary for the
Health Regulation Sector at
the UAE’s Ministry of Health
and Prevention (MoHAP),
stated the future of
medicine lies in precision
medicine. “The medicine
currently provided to
patients is one treatment
approach for various similar
diseases. However, this
approach may not always
succeed in treating patients
and could potentially lead
to adverse reactions,
negatively impacting their
health,” said His
Excellency.
“The medicine
of the future will be highly
personalized, taking into
account specific patient
factors such as their
illnesses through the
integration of gene therapy
and genotype or phenotype
analysis using blood tests,”
His Excellency added.
Also appearing at the
event, Dr. Thekra
Hasan Mohamed, Director of
Zayed Herbal Complex and
Life Sciences Projects,
noted that precision
medicine is a medical
approach that is
revolutionizing the way
patients are treated. “The
UAE has recognized the
tremendous potential of
precision medicine and has
embarked on a journey of
integrating this approach
into the country's
healthcare system. With the
launch of the largest
genomic study in the region,
the Emirati Genome Program,
we aim to focus on using the
latest technology and
scientific discoveries to
analyze genetic data,
monitor health status, and
provide personalized
treatment and care plans for
patients," she added.
In his welcome to
guests, Dr. Min S
Park, Chief Science Officer
and Director of Genomic
Medicine at Sanimed
International Labs and
Management – who
serves as Chairman of the
PMES Scientific Committee –
stated: “The opportunity for
precision medicine in the
Middle East is simply
enormous, because it opens
completely new preventive
measures based on advanced
basic research, technology
innovation in automation,
and AI, allowing the rapid
discovery of screening,
diagnostics, and treatment
options ahead of time.
“Most of all, precision
medicine can effectively
address the region’s high
frequencies of various
genetic and non-genetic
diseases. Toward achieving
the goal, most of the GCC
has been heavily investing
in national programs, such
as the Emirati Genome
Program, which will improve
the quality of patients’
lives tremendously.”
And finally, Kinjal
Zaveri, CEO of One Health, a
subsidiary of PureHealth
Group – the largest
integrated healthcare
platform in the region, and
Platinum Sponsor of PMES 23
– commented: “Our support of
the PrecisionMed Exhibition
& Summit reflects our
group’s unwavering
commitment to driving
transformative change in
healthcare. We are proud to
be at the forefront of this
movement, leveraging our
group’s expertise,
resources, and capabilities
to showcase innovative and
personalized healthcare
solutions that positively
impact patient outcomes and
shape the healthcare
landscape of tomorrow. We
remain committed to
contributing to the
advancement of precision
medicine in the region in
line with our vision to
unlock time for humankind by
ensuring people live longer,
fuller and healthier lives."
PMES 23 is supported
by the UAE’s MoIAT, MoHAP,
DoH Abu Dhabi, and the Dubai
Health Authority (DHA).
PRINT
THIS ARTICLE
font>/a>
|